Understanding barriers to diabetes self-care is the first step in facilitating providers to identify their role in enabling patients to
Read More »Yearly Archives: 2009
Eat More, Move Less, and You Will Pay More
To help cut medical costs, your insurance company may soon be raising premiums if you have unhealthy habits such as
Read More »New Fat-Fighting Pathway Discovered
Researchers have discovered a process that controls the amount of fat that cells store for use as a back-up energy source. Disruption of this process allows
Read More »Obesity and Diabetes Can Increase the Risk for Restless Legs Syndrome
The research found men and women with a body mass index (BMI) score over 30 were nearly one-and-a-half times more likely to have RLS than people
Read More »What Is a Normal A1c for Type 2 Children?
According to the ADA and AACE, a normal A1c result is from 4-6%. Yet we know the closer you get to 6% means your average blood glucose is getting higher and increases your risk for pre-diabetes and diabetes.
Read More »On-Demand Care for Diabetics May Not Help
Diabetic adults using same-day medical scheduling to manage their care fared no better and, in some aspects, saw their condition worsen, compared with those who
Read More »Liraglutide Has Low CVD Risk but May Be Blocked for Approval
Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of
Read More »The Next DPP-4 Inhibitor Onglyza™ Passes CVD Review: Coming Soon
An FDA panel voted 10-2 that the investigational diabetes drug saxagliptin (Onglyza) does not put Type 2 diabetes patients at an increased risk for cardiovascular events, but wants drugmaker Bristol-Myers Squibb to
Read More »Exenatide Vs. Sitagliptin feature
Effects of Exenatide versus Sitagliptin on Postprandial Glucose, Insulin, and Glucagon Secretion, Gastric Emptying, and Caloric Intake: A Randomized, Crossover Study
Read More »Insulin Use and Exercise, Part 2: Longer-Acting, Basal Insulins
Insulin Use and Exercise, Part 2: Longer-Acting, Basal Insulins
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.